Literature DB >> 21695523

Muscle ceramide content is similar after 3 weeks' consumption of fat or carbohydrate diet in a crossover design in patients with type 2 diabetes.

J W Helge1, L Tobin, T Drachmann, L I Hellgren, F Dela, H Galbo.   

Abstract

This study aimed at investigating the effect of prolonged adaptation to fat- or carbohydrate-rich diet on muscle ceramide in type 2 diabetes patients, using a longitudinal crossover study. Eleven type 2 diabetes patients consumed isocaloric fat- or carbohydrate-rich diet for 3 weeks in random order. After each dietary intervention period, muscle glycogen, triacylglycerol and ceramide content and plasma concentrations of insulin, adiponectin, glucose and FFA were determined. Insulin resistance was assessed by HOMA2 calculation. After the dietary period, plasma glucose and insulin, insulin sensitivity, muscle glycogen, triacylglycerol and ceramide content were similar. Plasma adiponectin concentration was significantly higher after fat compared with carbohydrate-rich diet. Results indicated that following fat-rich diet intake muscle ceramide and triacylglycerol concentrations were not different compared with that after carbohydrate-rich diet. Furthermore, plasma adiponectin concentration was higher after fat-rich compared with carbohydrate-rich diet, but insulin sensitivity remained similar despite the major difference in dietary macronutrient composition.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21695523     DOI: 10.1007/s00421-011-2041-x

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  48 in total

1.  Elevated plasma interleukin-18 is a marker of insulin-resistance in type 2 diabetic and non-diabetic humans.

Authors:  Christian P Fischer; Lisbeth B Perstrup; Annika Berntsen; Peter Eskildsen; Bente K Pedersen
Journal:  Clin Immunol       Date:  2005-08-19       Impact factor: 3.969

2.  Skeletal muscle triglyceride levels are inversely related to insulin action.

Authors:  D A Pan; S Lillioja; A D Kriketos; M R Milner; L A Baur; C Bogardus; A B Jenkins; L H Storlien
Journal:  Diabetes       Date:  1997-06       Impact factor: 9.461

3.  A procedure for fractionation of sphingolipid classes by solid-phase extraction on aminopropyl cartridges.

Authors:  J Bodennec; O Koul; I Aguado; G Brichon; G Zwingelstein; J Portoukalian
Journal:  J Lipid Res       Date:  2000-09       Impact factor: 5.922

Review 4.  Role of fatty acids in the pathogenesis of insulin resistance and NIDDM.

Authors:  G Boden
Journal:  Diabetes       Date:  1997-01       Impact factor: 9.461

Review 5.  Ceramides in insulin resistance and lipotoxicity.

Authors:  Scott A Summers
Journal:  Prog Lipid Res       Date:  2005-12-19       Impact factor: 16.195

6.  Adiponectin resistance precedes the accumulation of skeletal muscle lipids and insulin resistance in high-fat-fed rats.

Authors:  Kerry L Mullen; Janet Pritchard; Ian Ritchie; Laelie A Snook; Adrian Chabowski; Arend Bonen; David Wright; David J Dyck
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-12-10       Impact factor: 3.619

7.  Exercise and training effects on ceramide metabolism in human skeletal muscle.

Authors:  Jørn Wulff Helge; Agnieszka Dobrzyn; Bengt Saltin; Jan Gorski
Journal:  Exp Physiol       Date:  2004-01       Impact factor: 2.969

8.  Relationship between insulin sensitivity and sphingomyelin signaling pathway in human skeletal muscle.

Authors:  Marek Straczkowski; Irina Kowalska; Agnieszka Nikolajuk; Stella Dzienis-Straczkowska; Ida Kinalska; Marcin Baranowski; Malgorzata Zendzian-Piotrowska; Zofia Brzezinska; Jan Gorski
Journal:  Diabetes       Date:  2004-05       Impact factor: 9.461

9.  Utilization of skeletal muscle triacylglycerol during postexercise recovery in humans.

Authors:  B Kiens; E A Richter
Journal:  Am J Physiol       Date:  1998-08

10.  Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes.

Authors:  M Straczkowski; I Kowalska; M Baranowski; A Nikolajuk; E Otziomek; P Zabielski; A Adamska; A Blachnio; J Gorski; M Gorska
Journal:  Diabetologia       Date:  2007-08-28       Impact factor: 10.122

View more
  2 in total

1.  Intramyocellular Ceramides: Subcellular Concentrations and Fractional De Novo Synthesis in Postabsorptive Humans.

Authors:  Jin Ook Chung; Christina Koutsari; Agnieszka U Blachnio-Zabielska; Kazanna C Hames; Michael D Jensen
Journal:  Diabetes       Date:  2017-05-08       Impact factor: 9.461

2.  Dietary Fat and Protein Intake in Relation to Plasma Sphingolipids as Determined by a Large-Scale Lipidomic Analysis.

Authors:  Jowy Yi Hoong Seah; Wee Siong Chew; Federico Torta; Chin Meng Khoo; Markus R Wenk; Deron R Herr; E Shyong Tai; Rob M van Dam
Journal:  Metabolites       Date:  2021-02-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.